Versor Investments LP Buys Shares of 11,700 Xometry, Inc. $XMTR

Key Points

• Versor Investments LP acquired 11,700 shares of Xometry, Inc. for approximately $292,000, highlighting increased interest from institutional investors in the company.
• Analysts have shown a positive outlook for Xometry, with several firms raising their target prices significantly, leading to a current consensus rating of "Moderate Buy" and an average target price of $40.44.
• Xometry reported a 22.6% year-over-year revenue increase for the last quarter, achieving $162.55 million while exceeding analyst expectations for revenue and EPS.

Versor Investments LP bought a new stake in Xometry, Inc. (NASDAQ:XMTR - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 11,700 shares of the company's stock, valued at approximately $292,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Federated Hermes Inc. grew its holdings in shares of Xometry by 264.2% during the 1st quarter. Federated Hermes Inc. now owns 37,271 shares of the company's stock worth $929,000 after purchasing an additional 27,036 shares in the last quarter. State of Wyoming raised its stake in shares of Xometry by 8.2% in the fourth quarter. State of Wyoming now owns 8,876 shares of the company's stock valued at $379,000 after purchasing an additional 676 shares in the last quarter. Vontobel Holding Ltd. bought a new position in Xometry in the first quarter worth $420,000. GAMMA Investing LLC lifted its position in Xometry by 6,381.9% in the first quarter. GAMMA Investing LLC now owns 25,020 shares of the company's stock worth $623,000 after purchasing an additional 24,634 shares during the period. Finally, SG Americas Securities LLC lifted its position in Xometry by 259.0% in the first quarter. SG Americas Securities LLC now owns 50,035 shares of the company's stock worth $1,247,000 after purchasing an additional 36,097 shares during the period. Institutional investors and hedge funds own 97.31% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on XMTR shares. UBS Group raised their target price on Xometry from $35.00 to $40.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 6th. The Goldman Sachs Group raised their target price on Xometry from $33.00 to $42.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. JPMorgan Chase & Co. raised their target price on Xometry from $36.00 to $38.00 and gave the stock an "overweight" rating in a research report on Tuesday, June 3rd. Citigroup reaffirmed an "outperform" rating on shares of Xometry in a research report on Friday, July 11th. Finally, Royal Bank Of Canada raised their target price on Xometry from $32.00 to $36.00 and gave the stock a "sector perform" rating in a research report on Wednesday, May 7th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $40.44.

Insiders Place Their Bets

In other Xometry news, CEO Randolph Altschuler sold 9,332 shares of the business's stock in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $32.39, for a total transaction of $302,263.48. Following the completion of the sale, the chief executive officer directly owned 319,602 shares of the company's stock, valued at approximately $10,351,908.78. The trade was a 2.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 9.66% of the company's stock.

Xometry Stock Performance

Xometry stock opened at $46.57 on Friday. The stock has a 50-day simple moving average of $36.27 and a 200 day simple moving average of $31.39. The company has a quick ratio of 3.85, a current ratio of 3.91 and a debt-to-equity ratio of 1.20. Xometry, Inc. has a 12-month low of $16.11 and a 12-month high of $48.60. The stock has a market capitalization of $2.37 billion, a price-to-earnings ratio of -37.86 and a beta of 0.83.

Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.04. The business had revenue of $162.55 million during the quarter, compared to analysts' expectations of $156.53 million. Xometry had a negative return on equity of 6.79% and a negative net margin of 10.20%.The firm's revenue for the quarter was up 22.6% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.01) earnings per share. Xometry has set its Q3 2025 guidance at EPS. On average, research analysts anticipate that Xometry, Inc. will post -0.66 earnings per share for the current fiscal year.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Want to see what other hedge funds are holding XMTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xometry, Inc. (NASDAQ:XMTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.